Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and ...
Industry stakeholders want the US Food and Drug Administration (FDA) to expand the scope of its recent draft guidance on the ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Office of Prescription Drug Promotion (OPDP) has issued an untitled letter to Alar Pharmaceuticals, accusing the company of ...
Center for Biologics Evaluation and Research (CBER) has issued a guidance to assist sponsors in assessing potency assays for ...
The UK government has filed legal amendments intended to modernize the regulation of medicines and medical devices. Through the amendments, the government could change the law on sharing information ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Drug manufacturing process models represent a "growing area" of scientific development and are increasingly being utilized in ...
The US Food and Drug Administration (FDA) is seeking feedback on a competency-based approach to regulating medical devices ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results